• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Aug 16;27(10).
doi: 10.3201/eid2710.210080. Online ahead of print.
Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students

Sarah C Tinker, Christine M Szablewski, Anastasia P Litvintseva, Cherie Drenzek, Gary E Voccio, Melissa A Hunter, Stephen Briggs, Debbie E Heida, Jennifer Folster, Patricia L Shewmaker, Magdalena Medrzycki, Michael D Bowen, Caitlin Bohannon, Dennis Bagarozzi Jr, Marla Petway, Paul A Rota, Wendi Kuhnert-Tallman, Natalie Thornburg, Jessica L Prince-Guerra, Lisa C Barrios, Azaibi Tamin, Jennifer L Harcourt, Margaret A Honein, CDC Sample Collection Team,1; CDC Surge Laboratory Group1

Abstract

We used the BinaxNOW COVID-19 Ag Card to screen 1,540 asymptomatic college students for severe acute respiratory syndrome coronavirus 2 in a low-prevalence setting. Compared with reverse transcription PCR, BinaxNOW showed 20% overall sensitivity; among participants with culturable virus, sensitivity was 60%. BinaxNOW provides point-of-care screening but misses many infections.

Keywords: 2019 novel coronavirus disease; COVID-19; SARS-CoV-2; adolescents; antigen testing; asymptomatic; colleges; coronavirus disease; coronaviruses; institutions of higher education; respiratory infections; severe acute respiratory syndrome coronavirus 2; universities; viruses; young adults; zoonoses.
 
Back
Top Bottom